






A	   decade	   of	   DNA-­‐hybrid	   catalysis:	   from	   innovation	   to	  
comprehension	  	  
Nicolas	   Duchemin,a	   Isabelle	   Heath-­‐Apostolopoulos,a	   Michael	   Smietana,b,*	   Stellios	  
Arseniyadisa,*	  
During	   a	   bit	   over	   a	   decade,	   the	   unique	   chirality	   of	   oligonucleotides	   has	   allowed	   the	   development	   of	   a	   variety	   of	  
asymmetric	  synthetic	  transformations.	  The	  concept	  lies	  in	  embedding	  an	  achiral	  transition	  metal	  catalyst	  in	  a	  DNA	  double	  
helix,	   which	   provides	   the	   necessary	   chiral	   microenvironment	   to	   selectively	   form	   one	   enantiomer	   of	   a	   given	   reaction	  
product.	  The	  most	  recent	  efforts	  to	  unveil	  new	  reactivities	  have	  been	  accompanied	  with	  the	  willingness	  to	  understand	  the	  
mechanisms	   by	   which	   the	   chirality	   is	   transferred	   and	   the	   influence	   of	   the	   interaction	   between	   DNA	   and	   the	   metallic	  
co-­‐factor	   on	   the	   selectivity.	   By	   offering	   a	   complete	   overview	   of	   the	   field,	   this	   review	   intends	   to	   highlight	   the	   intricate	  
correlation	  between	  the	  structure	  of	  the	  chiral	  bio-­‐inorganic	  scaffold	  and	  its	  catalytic	  efficacy.	  
	  
1. Introduction	  
The	   development	   of	   efficient	   catalytic	   systems	   capable	   of	  
promoting	   asymmetric	   transformations	   is	   one	   of	   the	   corner	  
stone	   of	   synthetic	   chemistry.	   While	   a	   plethora	   of	   catalytic	  
enantioselective	   transformations	   have	   been	   developed	   over	  
the	   years,	   most	   of	   them	   imply	   the	   use	   of	   usually	   rare	   and	  
expensive	   metals	   or	   chiral	   ligands.	   The	   use	   of	   biomolecules,	  
which	   exhibit	   an	   inherent	   chirality,	   has	   been	   much	   less	  
exploited	   in	   the	   context	   of	   asymmetric	   catalysis.	   The	  
combination	   of	   these	   natural	   chiral	   objects	   with	   a	   specific	  
metal	   appears	   to	   be	   an	   appealing	   approach	   for	   asymmetric	  
synthesis	   and	   bio-­‐inspired	   catalysis	   logically	   became	   a	  
particularly	   attractive	   tool,	   combining	   homogeneous	   catalysis	  
and	  bio-­‐catalysis.	  These	  bio-­‐inspired	  catalysts,	  which	  exhibit	  a	  
chiral	   micro-­‐environment	   generated	   by	   the	   ligation	   of	   a	  
metallic	  co-­‐factor	  to	  a	  macromolecule,	  have	  been	  engaged	  in	  a	  
wide	   range	   of	   enantioselective	   transformations.1-­‐10	  
Interestingly,	  most	  of	  these	  systems	  involve	  the	  use	  of	  proteins	  
and	   it	   is	   only	   in	   the	   last	   decade	   that	   DNA-­‐based	   asymmetric	  
catalysis	   emerged	   as	   a	   convincing	   approach,	   taking	   profit	   of	  
the	   powerful	   chirality	   imposed	   by	   the	   DNA	   double	   helix.	  
Moreover,	   the	   good	   accessibility	   of	   various	   and	   defined	  
structures	   by	   highly	   effective	   automated	   oligonucleotide	  
synthesis	  processes	  renders	  the	  concept	  even	  more	  attractive.	  
	   The	   concept	   of	   DNA-­‐based	   asymmetric	   catalysis	   was	   first	  
introduced	   by	   Roelfes	   and	   Feringa	   in	   2005.11	   It	   relies	   on	   the	  
use	   of	   an	   achiral	   transition	   metal	   catalyst	   imbedded	   in	   the	  
DNA	   double	   helix,	   which	   provides	   the	   necessary	   chiral	  
microenvironment	   to	   selectively	   form	   one	   enantiomer	   of	   a	  
given	  reaction	  product.	  As	  depicted	  in	  previous	  reviews	  in	  the	  
field,12-­‐17	   a	   handful	   of	   highly	   enantioselective	   catalytic	  
transformations	   have	   been	   carried	   out	   successfully,	   while	  
several	   investigations	   have	   looked	   into	   deciphering	   the	  
influence	  on	  the	  selectivity	  of	  each	  parameter,	  in	  particular	  the	  
influence	  of	   the	  oligonucleotide,	   its	   topology,	  or	   the	  effect	  of	  
the	  achiral	  metallic	  co-­‐factor.	  This	  review	  intends	  to	  provide	  a	  
complete	  overview	  of	   the	   field	  with	  a	   special	   emphasis	   given	  
to	   the	   role	   of	   the	   ligands,	   their	   binding	   modes,	   and	   the	  
different	   DNA	   architectures	   that	   have	   been	   used	   so	   far.	   We	  
believe	   that	   this	   approach	   allows	   one	   to	   unveil	   more	  
accurately	   the	   correlation	   between	   structure	   and	   selectivity,	  
but	  also	  pays	  tribute	  to	  the	   improvements	  that	  were	  made	  in	  
the	   control	   and	   understanding	   of	   natural	   or	   synthetic	  
oligonucleotide	  assemblies.	  
2. Supramolecular	  approach	  
For	  a	  chemist	  seeking	  to	  use	  the	  chirality	  of	  a	  macromolecule	  
to	   achieve	   an	   enantioselective	   transformation,	   the	   most	  
straightforward	   approach	   would	   be	   to	   incorporate	   an	   active	  
catalytic	  centre	  in	  the	  vicinity	  of	  the	  macromolecule	  in	  order	  to	  
create	  an	  appropriate	  chiral	  microenvironment.	  In	  this	  context,	  
Roelfes	   and	   Feringa11	   developed	   a	   supramolecular	   approach	  
which	   relied	  on	   the	  assembly	  of	  a	  DNA	  duplex	  and	  an	  achiral	  
catalyst.	  They	  precisely	  characterized	  the	  binding	  modes	  of	  the	  
catalytically	  active	  complexes	  which	  allowed	  a	  classification	  of	  
the	  ligands	  used	  in	  two	  main	  groups:	  intercalators	  (L1-­‐L10)	  and	  
groove	   binders	   (L11-­‐L12),18-­‐19	   while	   another	   class	   of	   groove	  
binders	  based	  on	  the	  Hoechst	  33258	  was	  recently	   introduced	  
by	  our	  group	  (L13-­‐L16)	  (Figure	  1).20	  This	  purely	  structural	  detail	  
is	  actually	  of	  the	  highest	  importance	  as	  it	  defines	  the	  geometry	  
of	   the	  catalytic	  pocket	  and	  therefore	  enantioselectivity	  of	   the	  










L1: (n = 2) R = 3,5-dimethoxyphenyl
L2: (n = 3) R = 3,5-dimethoxyphenyll
L3: (n = 2) R = 1-naphthyl









L5: R = H
L6: R = Me
L7
L8: R = H



















L11: R = H
L12: R = Me
L13: (n = 2) R = 3,5-diméthoxyphenyl
L14: (n = 3) R = 3,5-diméthoxyphenyl
L15: (n = 2) R = 1-naphthyl




Figure 1. DNA-intercalating (A) or minor groove binding (B) ligands







2.1	  Intercalative	  approach	  	  
The	  intercalation,	  which	  can	  be	  described	  as	  the	  positioning	  of	  
the	  metallic	   co-­‐factor	   between	   two	   base	   pairs	   of	   a	   duplex,21	  
was	   the	   first	   approach	   envisaged	   in	   DNA-­‐hybrid	   catalysis.	  
Roelfes,	   Feringa	   and	   co-­‐workers	   developed	   a	   copper(II)-­‐
catalysed	  Diels-­‐Alder	   reaction	  between	   an	   azachalcone	  1	   and	  
cyclopentadiene	   2	   in	   an	   aqueous	   media	   using	   commercially	  
available	   salmon	   testes	   DNA	   (st-­‐DNA)	   (Scheme	  1).11	   The	  
generation	  of	  the	  catalytically	  active	  chiral	  micro-­‐environment	  
was	  ensured	  by	   incorporating	  a	   copper(II)-­‐binding	   site	  onto	  a	  
spacer	  itself	  covalently	  bound	  to	  an	  acridine	  moiety,	  known	  to	  
be	   an	   excellent	   DNA	   intercalating	   agent.22	   Various	   acridine-­‐
derived	  ligands,	  differing	  by	  the	  nature	  of	  the	  substituents	  on	  
the	   ligation	   site	   or	   by	   the	   length	   of	   the	   spacer,	   were	   thus	  
tested	   and	   some	   particularly	   encouraging	   enantioselectivities	  
were	   achieved.	   Indeed,	   enantiomeric	   excesses	   as	   high	   as	  
(−)	  53%	   were	   obtained	   using	   the	   3,5-­‐dimethoxybenzyl-­‐
substituted	   ligand	   (L1)	   with	   an	   excellent	   endo/exo	   selectivity	  








These	  results	  were	  later	  improved	  by	  slightly	  modifying	  the	  
structure	   of	   the	   dienophile.	   Indeed,	   by	   replacing	   the	   pyridyl	  
group	  in	  1	  by	  a	  2-­‐methylimidazole	  and	  conducting	  the	  reaction	  
under	  otherwise	  identical	  conditions,	  Boersma	  et	  al.	  were	  able	  
to	   increase	   the	   ee	   to	   up	   to	   (+)	   68%	   (Scheme	   2).23	   It	   was	  
demonstrated	   that	   for	  effective	  enantioselectivity,	   the	   spacer	  
length	   and	   R1	   group	   (Figure	   1)	   both	   played	   a	   vital	   role	   as	  
significant	   ees	  were	   only	   observed	  when	   the	   R1	   group	  was	   a	  
1-­‐napthylmethyl	   or	   a	   3,5-­‐methoxybenzyl	   (L1-­‐L4).	   The	   most	  
effective	   ligands	   proved	   to	   be	   those	   containing	   arylmethyl	  
groups	   supporting	   the	   idea	   that	   π-­‐π	   stacking	   interactions	  
occurred	  with	  the	  dienophile	  substrate.24	  The	  influence	  of	  the	  
length	   of	   the	   spacer	   also	   highlighted	   the	   importance	   of	   the	  
proximity	   to	   the	  duplex	   for	  an	  efficient	  chirality	   transfer	  onto	  
the	   Diels-­‐Alder	   product	   as	   a	   decrease	   in	   selectivity	   was	  
observed	  when	  increasing	  the	  number	  of	  carbons	  between	  the	  
acridine	  and	  the	  copper(II)-­‐ligation	  site	  (L2,	  Figure	  1).11,23	  	  
	   Although	  DNA	  is	  a	  powerful	  source	  of	  chirality,	   it	  was	  also	  
found	  to	  decrease	  the	  reaction	  rates	  quite	  significantly.25	  This	  
rather	   unfortunate	   discovery	   was	   counterbalanced	   by	   the	  
observation	   of	   a	   strong	   influence	   of	   the	   oligonucleotidic	  
sequence.	  Indeed,	  the	  chiral	  microenvironment	  created	  by	  the	  
base	   pairs	   seams	   to	   affect	   the	   selectivity.	   Sequences	   with	  
alternating	  GC	  base	  pairs	  were	  found	  to	  be	  the	  most	  effective,	  
affording	  up	  to	  62%	  ee	  with	  the	  poly(dG-­‐dC).	  These	  results	  are	  
consistent	  with	   acridine’s	   preference	   for	   GC/CG	   base	   pairs;26	  
the	   reaction	   therefore	   predominantly	   takes	   place	   within	   the	  
duplex	  scaffold.	  
	   In	   a	   parallel	   study,	   the	   authors	   investigated	   the	   use	   of	  
intercalating	  polypyridyl-­‐based	  copper(II)-­‐ligands	  on	  which	  the	  
DNA	  intercalator	  and	  metal-­‐binding	  moiety	  are	  combined	  into	  
one	   (L5-­‐L10).27	   Remarkably,	   for	   this	   class	   of	   ligand,	   a	   reverse	  
correlation	   between	   binding	   affinity	   and	   the	   selectivity	  
outcome	  was	   observed.	   Through	   the	   lens	   of	   this	   review,	   this	  
particularity	   is	   actually	  of	   the	  highest	   importance	  as	   it	   seems	  
to	   imply	   that	   the	   intercalative	   approach	   is	   not	   necessarily	  
appropriate	   for	   the	   design	   of	   robust	   and	   efficient	   catalytic	  
pockets.	   However,	   high	   selectivities	   could	   be	   achieved	   using	  
these	  derivatives,	  with	  ees	  up	  to	  (+)	  73%	  (L8)	  (Scheme	  2).28	  	  
	   Intercalating	   ligands	  were	  also	  applied	  to	  other	  copper(II)-­‐
catalysed	   reactions.	   The	   groups	   of	   Roelfes	   and	   Feringa	   first	  
reported	   the	   DNA-­‐mediated	   enatioselective	   syn-­‐hydration	   of	  
acylimidazole	   derivatives	   such	   as	   4,	   unprecedented	   in	  
asymmetric	   catalysis	   (Scheme	  3).29	   With	   acridine-­‐based	  
copper(II)-­‐ligands	   (L1-­‐L4),	   the	   reaction	   afforded	   extremely	  
encouraging	  selectivities	  [ee	  up	  to	  (+)	  72%	  with	  L1].	  It	  is	  worth	  
noting	   that	   the	   hydration	   reaction	   is	   reversible,	   making	   the	  
selectivity	  strongly	  dependent	  on	  both	  the	  conversion	  and	  the	  




	   A	   detailed	   analysis	   set	   the	   optimal	   reaction	   time	   to	  
24	  hours,	   after	   which	   epimerisation	   occured	   although	  
conversion	   kept	   increasing.	   A	   deeper	   investigation	   of	   the	  
enantioselectivity	   outcome	   of	   the	   reaction	   was	   later	  
conducted.30	  Mechanistically,	   the	   hydration	   was	   found	   to	   be	  
strongly	   differing	   from	   the	   Diels-­‐Alder	   reaction.	   Indeed,	   the	  
use	   of	   water	   as	   nucleophile	   and	   its	   presence	   in	   the	   DNA	  
solvation	   sphere	   completely	   changed	   the	   story,	   and	   it	   was	  
demonstrated	  that	  for	  the	  reaction	  to	  occur	  with	  high	  levels	  of	  
enantioselectivity,	   the	   metal	   co-­‐factor	   had	   to	   be	   correctly	  
positioned	  in	  the	  proximity	  of	  water	  molecules	  composing	  the	  
hydration	   layer	   of	   the	   grooves.	   The	   hydration	   method	   was	  
later	   applied	   to	   a	   one	   pot	   TEMPO-­‐mediated	  
oxidation/enantioselective	  hydration	  cascade.31	  Although	  only	  
modest	   enantioselectivities	   were	   obtained,	   this	   proved	   DNA-­‐
mediated	   catalysis	   could	   easily	   be	   implemented	   in	   cascade	  
processes.	  	  
	   This	   DNA-­‐catalysed	   C-­‐O	   bond	   forming	   process	   was	   later	  
applied	   to	   the	   oxa-­‐Michael	   reactions	   (Scheme	   4).32	  
Enantioselectivities	  up	  to	  (+)	  86%	  were	  reported	  using	  MeOH,	  









endo/exo up to 98:2
up to 53% ee (endo)
up to 90% ee (exo)





L1 [ee = (−) 53%], L2 [ee = (−) 37%]
L3 [ee = (+) 49%], L4 [ee =(+) 49%]
L5 [ee = (+) 49%], L7 [ee = (+) 61%]
L8 [ee = (+) 73%], L10 [ee = (−) 60%]





MOPS (pH 6.5), 5 °C




















L1 [ee = (+) 29%], L2 [ee =  (+) 68%]
L3 [ee = (+) 10%], L4 [ee = (+) 16%]

















MES (pH 5.5), 5 °C4 76
H2O
7a R1 = Me [ee = (+) 28%]
7b R1 = n-Pentyl [ee = (+) 47%]
Scheme 3. syn-Hydration of acylimidazoles
Scope (L1)R1 = t-Bu
L1 [ee = (+) 72%], L2 [ee = (+) 24%]
L3 [ee = (+) 55%], L4 [ee = (+) 20%]
7c R1 = i-Pr [ee = (+) 60%]
7d R1 = t-Bu [ee = (+) 72%]
	  
	  
as	  co-­‐solvents	  with	  water,	  which	  logically	  led	  to	  the	  formation	  




	   In	  all	  the	  reactions	  reported	  so	  far,	  the	  metallic	  center	  was	  
used	   as	   a	   Lewis	   acid	   to	   increase	   the	   electrophilicity	   of	   the	  
enone.	   The	  development	  of	   an	  organometallic-­‐based	  method	  
involving	   DNA	   raised	   a	   certain	   number	   of	   questions	   as	  
transition	  metal	  catalysts	  are	  usually	  poorly	  soluble	  or	  prone	  to	  
degradation	   in	   aqueous	  media.	  Nevertheless,	  Roelfes	   and	   co-­‐
workers	   took	   advantage	   of	   the	   intercalative	   approach	   to	  
develop	   the	   first	   example	   of	   a	   DNA-­‐mediated	   Cu(I)-­‐catalysed	  
asymmetric	  intramolecular	  cyclopropanation	  of	  α-­‐diazo-­‐β-­‐keto	  
sulfones	  10	   (Scheme	  5).33	  Through	  the	  formation	  of	  a	  copper-­‐
carbenoid	   intermediate,	   the	   mechanism	   leads	   to	   the	  
cyclization	  on	   the	   terminal	   alkene	  and	   therefore	   requires	   the	  
generation	   of	   Cu(I).	   This	   was	   easily	   achieved	   by	   reducing	  




	   The	  authors	  also	  demonstrated	  that	  both	  the	  reactivity	  and	  
the	   selectivity	  were	   intricately	  dependent	  on	   the	  presence	  of	  
the	   bio-­‐inorganic	   complex	   formed	   between	   DNA	   and	   the	  
ligand	   (L5-­‐L9).	  This	   study	  also	   revealed	   the	   importance	  of	   the	  
binding	   affinity	   for	   the	   reaction	   outcome.	   Indeed,	   a	   strongly	  
intercalating	   ligand	   such	   as	   L9	   was	   required	   to	   form	   a	   very	  
stable	  catalytic	  pocket	  within	  the	  DNA,	  thus	  	  limiting	  the	  access	  
of	  water	  molecules	  surrounding	  the	  substrastes.	  Ees	  as	  high	  as	  
86%	  were	   obtained	  which	   proved	   that	   oligonucleotide-­‐based	  
organometallic	  catalysis	  could	  be	  envisioned.	  
	   The	   intercalative	   approach	   truly	   initiated	   DNA-­‐hybrid	  
catalysis	   with	   the	   use	   of	   synthetically	   accessible	   ligands	  
genuinely	   binding	   to	  DNA	  by	   intercalation	  between	   two	  base	  
pairs.	   Various	   other	   anchorage	   strategies	   have	   however	   also	  
been	  investigated	  such	  as	  the	  groove	  binding-­‐	  and	  the	  covalent	  
approach.	  	  
	  
2.2	  Groove	  binding	  approach	  
Taking	   advantage	   of	   the	   harnessing	   existing	   between	  
oligonucleotide	   duplexes	   and	   ligands	   in	   asymmetric	   catalysis	  
requires	   a	   clever	   mix	   between	   three	   main	   parameters:	  
efficient	   chirality	   transfer,	   increased	   reactivity	   and	   duplex-­‐
ligand	   high	   affinity.	   The	   intercalating	   approach	   brought	  
extremely	   satisfying	   results	   in	   terms	   of	   chirality	   transfer	   and	  
diversity	   in	   catalysis.	   Yet,	   several	   studies	   showcased	   that	  
reactivity	   and	   affinity	  weren’t	   necessarily	   correlated	  with	   the	  
highest	  enantioselectivities.25,27	  Although	  completing	  this	  triad	  
seems	   highly	   challenging,	   it	   somehow	   sounds	   relevant	   to	  
associate	   these	   three	  parameters	   to	  obtain	   efficient	   systems.	  
The	  use	  of	  alternative	  binding	  modes	  was	  therefore	  envisaged	  
to	   achieve	   this	   goal.	   Oligonucleotide	   duplexes	   present	   two	  
dissymmetric	   grooves	   resulting	   from	   the	   association	   of	   both	  
strands	   independently	   of	   the	   topology	   they	   adopt.	   In	   the	  
B-­‐type	   helix,	   the	   major	   groove	   is	   22	  Å	   wide	   and	   therefore	  
easily	  accessible	  whereas	  the	  minor	  groove	  is	  narrower,	  with	  a	  
12	  Å	   gap	   between	   successive	   strands.	   Thus,	   both	   represent	  
interesting	   sites	   for	   asymmetric	   catalysis	   and	   were	   rapidly	  
targeted.	  
	   The	   groove	   binding	   strategy	   was	   first	   envisaged	   with	  
bipyridine-­‐based	   ligands	   (L11-­‐L12,	   Figure	   1)18	   in	   the	   copper-­‐
catalysed	   reactions	   previously	   mentioned.23,27	   The	   use	   of	  
bypiridine	   (L11)	   and	   later	   of	   4,4’-­‐dimethyl-­‐2,2’-­‐bipyridyl	  
(dmbpy,	   L12)	   brought	   a	   dramatic	   increase	   in	   the	  
enantioselectivity	   compared	   to	   the	   intercalative	   approach,	  
with	  ees	  up	  to	  99%	  in	  the	  Diels-­‐Alder	  cycloaddition	  (Scheme	  6).	  
Remarkably,	   it	   was	   also	   found	   that	   the	   binding	   constants	   of	  




acridine-­‐based	   derivatives,	   thus	   ensuring	   a	   non	   labile	  
interaction	  with	   the	  duplex.27	   The	  use	  of	   L12,	   the	  best	   ligand	  
so	   far,	   was	   later	   fully	   investigated	   by	   Roelfes	   and	   Feringa.34	  
Kinetic	   experiments	   revealed	   that	   in	   comparison	   with	   purely	  
intercalative	   ligands,	   the	   sequence	   actually	   accelerated	   the	  
reaction.	   In	   comparison	   with	   the	   use	   of	   Cu(NO3)2	   alone,	   an	  
impressive	   58-­‐fold	   increase	   in	   the	   reaction	   rate	   could	   be	  
observed	   with	   st-­‐DNA	   and	   Cu(L12).	   Therefore,	   in	   terms	   of	  
reactivity	  and	  enantioselectivity,	  dmbpy	  (L12)	  rapidly	  appeared	  
















MOPS (pH 6.5), 5 °C4 98
R2OH
Scheme 4. Oxa-Michael additions of acylimidazoles
9a R1 = Me, R2 = Me [ee = (+) 64%]
9b R1 = n-Pentyl, R2 = Me [ee = (+) 25%]
9c R1 = i-Pr, R2 = Et [ee = (+) 52%]
Scope (L1)R1 = i-Pr, R2 = Me
9d R1 = i-Pr, R2 = i-Pr [ee = (+) 57%]
9e R1= i-Pr, R2 = n-Pent [ee = (+) 86%]
9f R1 = t-Bu, R2 = Me [ee = (+) 83%]
L1 [ee = (+) 64%]
L3 [ee = (+) 57%]






















11a R1 = H,  R2 = Ph [ee = (+) 84%]
11b R1 = Me,  R2 = Ph [ee = (+) 16%]
11c R1 = H, R2 = 2-pyridyl [ee = (+) 51%]
11d R1 = H,  R2  = p-tolyl [ee = (+) 63%]
Scope (L9)R1 = H,  R2 = Ph
L5 [ee = (+) 10%]
L7 [ee = (+) 28%]
L8 [ee = (+) 67%]





2 3 or 4
Scheme 6. Diels-Alder cycloaddition: influence of the ligands/sequences
L11-L12
MOPS (pH 6.5), 5 °C1 or 4
R1 = 2-pyridyl 
L11 [(+) 90% ee]
















(+) 99.45.00 x 10-1d(TCAGGGCCCTGA)2 9.59 x 103
2.98 x 10-2d(GCGCGCGC)2 (+) 869.42 x 103
-
R1 = 2-(1-methylimidazole)
L11 [(+) 87% ee]









	   The	   same	   group	   later	   observed	   that	   a	  
partial	   control	   of	   the	   enantioselectivity	  
outcome	  was	  possible	  with	  ligands	  such	  as	  L5-­‐
L10.28	   Indeed,	   when	   using	   terpyridine-­‐type	  
ligands	   (L10)	   Roelfes,	   Feringa	   and	   co-­‐workers	  
observed	   an	   inversion	   of	   the	   selectivity	  
obtained	  with	  bipyridine-­‐type	   ligands	  L11	   and	  
L12.	   This	   study	   clearly	   illustrates	   the	  
fundamental	   importance	  of	   the	  binding	  mode	  
between	   the	   metallic	   co-­‐factor	   and	   the	  
oligonucleotide	   duplex.	   The	   selectivity	   was	  
once	   again	   found	   to	   be	   sequence-­‐dependent.	  
However,	   a	   different	   trend	   was	   observed	   for	  
bipyridine-­‐based	   ligands.	   With	   L12,	   the	  
reaction	   reached	   99.4%	   ee	   with	   the	   12-­‐mer	  
oligonucleotide	   sequence	  d(TCAGGGCCCTGA)2,	   as	  opposed	   to	  
the	   preferred	   16-­‐mer	   sequence	   d(GACTGACTAGTCAGTC)2	   for	  
the	   intercalative	  binding	  mode	   (Scheme	  6).	   In	  addition	   to	   the	  
high	   enantioselectivity	   achieved	  with	   this	  DNA	   sequence,	   the	  
rate	  was	   also	   accelerated,	   twice	   as	   fast	   as	   the	   same	   reaction	  
with	   st-­‐DNA	   and	   100-­‐fold	   increase	   in	   comparison	   to	   the	  
catalysis	  in	  the	  absence	  of	  DNA.	  
	   The	   compatibility	   of	   the	   Diels-­‐Alder	   reaction	   in	   organic	  
co-­‐solvent	  was	   rapidly	   investigated.35	   As	   a	   general	   trend,	   the	  
reactions	   were	   most	   resilient	   to	   water-­‐miscible	   organic	  
solvents	   such	   as	   MeCN,	   alcohols,	   DMSO	   or	   DMF	   and	   could	  
handle	   up	   to	   33%	   v/v	   of	   the	   organic	   co-­‐solvent	   without	   any	  
noticeable	  loss	  in	  selectivity.	  Water	  non-­‐miscible	  solvents	  such	  
as	  CH2Cl2,	  ended	  up	  reducing	  both	  the	  ee	  and	  the	  conversion,	  
likely	   due	   to	   precipitation	   of	   the	   DNA.	   Any	   increase	   in	   the	  
concentration	   beyond	   this	   value	   led	   to	   a	   gradual	   decrease	   in	  
selectivity	   and	   reaction	   rate.	   A	   non	   negligible	   drop	   in	   KB(DNA)	  
(ligand	  binding	  constant	  to	  DNA)	  was	  concomitantly	  observed	  
at	   >10%	   v/v	   of	   organic	   solvent.	   Base	   pair	   sequence	   and	  
structure	  of	  the	  complex	  matter	  to	  the	  ee,	  as	  described	  earlier.	  
Thus,	  a	   slight	   change	   in	   the	   structure	  of	   the	  DNA	  can	   lead	   to	  
partial	  precipitation,	  which	  in	  turn	  can	  hamper	  the	  selectivity.	  
Also,	   as	   the	   reaction	   is	   accelerated	  by	   the	  presence	  of	  water	  
due	   to	   the	  hydrophobic	  effect,	   the	  gradual	  decrease	   in	  water	  
content	   leads	   to	   a	   logical	   drop	   in	   rates.	   Nevertheless,	   the	  
negligible	   influence	   on	   the	   enantioselectivity	   of	   high	  
concentrations	   of	   organic	   solvents	   allows	   one	   to	   imagine	   a	  
broader	   range	   of	   potential	   substrates	   for	   the	   different	  
reactions	  developed.	  
	   Along	   with	   the	   Diels-­‐Alder	   reaction,	   several	   copper-­‐
catalysed	   C-­‐C	   bond-­‐forming	   reactions	   were	   developed	   using	  
the	   highly	   efficient	   groove	   binding	   interaction.	   The	   Michael	  
reaction	   –	   conjugate	   addition	   of	   a	   carbon	  nucleophile,	   in	   the	  
form	  of	  an	  enolate,	  to	  an	  electron	  deficient	  carbon	  –	  was	  the	  
first	  to	  draw	  the	  attention	  of	  the	  community.	  However,	  while	  
highly	   enantioselective	   non	   DNA-­‐catalysed	   Diels-­‐Alder	  
reactions	   are	   well	   reported	   in	   the	   literature,36-­‐39	   only	   rare	  
examples	   with	   significant	   selectivities	   were	   obtained	   in	  
transition-­‐metal	   catalysed	   Michael	   additions	   in	   water	   (up	   to	  
86%	  ee).40	  Yet,	  DNA-­‐based	  catalysis	  rapidly	  enabled	  extremely	  
appealing	   enantioselectivities	   for	   the	   Michael	   additions	   of	  
both	   dimethyl	   malonate	   12	   and	   nitromethane	   14	   to	  
α,β-­‐unsaturated	   2-­‐acylimidazoles	   4	   (Scheme	  7).41	  
Unsurprisingly,	  L12	  was	  found	  to	  be	  the	  most	  effective	  ligand,	  
affording	  up	  to	  92%	  ee	  and	  85%	  ee	   for	  dimethyl	  malonate	  12	  
and	   nitromethane	   14	   respectively.	   Also,	   as	   expected	   for	  
bipyridine-­‐based	  groove	  binding	   ligands,	  the	  presence	  of	  DNA	  
was	   shown	   to	   accelerate	   the	   reaction	   with	   conversions	  
dropping	  from	  ≥75%	  to	  54%	  in	  the	  absence	  of	  DNA.	  Variation	  
in	   the	   R1	   group	   on	   the	   electrophile	   significantly	   affected	   the	  
selectivities	   as	   well,	   with	   ees	   ranging	   from	   58%	   to	   99%.	  
Interestingly,	  in	  sharp	  contrast	  with	  the	  malonate	  addition,	  the	  
lower	   reactivity	   of	   nitromethane	  was	   clearly	   showcased.	   The	  
reason	  unfortunately	   remains	  unclear	   as	   the	  proximity	   in	   the	  
pKas	  (13.0	  and	  10.3	  respectively)	  doesn’t	  make	  the	  enolisation	  
process	   accountable	   for	   the	   reactivity	   disparity.	   The	   use	   of	  
organic	   co-­‐solvents	  was	  also	   studied	   for	   the	  Michael	  addition	  
by	  Megens	  and	  Roelfes35	  who	  observed	  that	  the	  reaction	  was	  
less	   tolerant	   than	   the	   Diels-­‐Alder	   cycloaddition	   to	   high	  
concentrations	  of	  organic	  solvents	  as	  a	  decrease	   in	  selectivity	  
starts	  to	  appear	  beyond	  10%	  v/v.	  However,	  the	  reactivity	  was	  
proved	   to	   be	   positively	   impacted	   with	   a	   general	   increase	   in	  
conversion	   due	   to	   an	   acceleration	   of	   the	   dissociation	   step.	  
Later,	   Zhao	   and	   co-­‐workers	   took	   interest	   in	   the	   use	   of	   ionic	  
solvents	  and	  glymes	  as	  alternative	  co-­‐solvents	  in	  catalysis.42	  	  
	   Through	   a	   very	   detailed	   study,	   the	   authors	   observed	   that	  
additions	   of	   glymes,	   glycols,	   deep	   eutectic	   solvents	   or	   ionic	  
liquids	  in	  reasonable	  amounts	  had	  a	  negligible	  influence	  on	  the	  
structure	  of	  the	  double	  stranded	  DNA	  and	  could	  also,	  in	  some	  
cases,	  positively	   impact	  the	  enantioselectivity	  outcome	  of	  the	  
reactions.	   High	   selectivities	  were	   indeed	   obtained	   for	   a	  wide	  
range	  of	  substrates	  (up	  to	  >99%	  ee)	  with	  a	  0.4	  M	  concentration	  
of	   glycerol.	   Moreover,	   the	   introduction	   of	   these	   co-­‐solvents	  
allowed	   to	   conduct	   the	   Michael	   additions	   at	   higher	  
temperatures	  and	  thus	  drastically	  reduce	  the	  reaction	  times.	  
	   More	   recently,	   the	  group	  of	   Li	   reported	  a	  complementary	  
study	   on	   DNA-­‐mediated	   Michael	   additions	   using	   a	   groove	  
binding	   approach.43	   With	   the	   aim	   of	   widening	   the	   class	   of	  
useable	   nucleophiles,	   the	   authors	   took	   interest	   in	   the	  
conjugate	  addition	  of	  malonitrile	  and	  various	  cyanoacetates	  on	  
α,β-­‐unsaturated	  2-­‐acylimidazoles	  4	   using	   the	   same	  conditions	  
previously	   evoked	   (Scheme	   7).	   These	   nucleophiles	   proved	   to	  
be	   compatible	   with	   the	   reaction,	   with	   both	   good	   reactivities	  
and	   selectivities	   (up	   to	   84%	   ee).	   Only	   very	   moderate	  
diastereoselectivity	   could	   unfortunately	   be	   observed.	  
Interestingly,	   it	   was	   observed	   that	   the	   use	   of	   electron-­‐
withdrawing	   groups	   (such	   as	   p-­‐	   or	   o-­‐bromophenyl)	   on	   the	  
electrophile	   was	   detrimental	   for	   the	   enantioselectivity	   when	  
malonitrile	   was	   used	   as	   the	   nucleophile.	   This	   selectivity	  
discrepancy	  was	  not	  observed	  by	  the	  group	  of	  Roelfes	  with	  the	  
addition	   of	   dimethyl	   malonate	   12	   and	   nitromethane	   14.	   On	  
the	  other	  hand,	   the	  addition	  of	  unsymmetrical	   cyanoacetates	  
(13b-­‐d)	   was	   proved	   to	   be	   less	   affected	   by	   the	   electrophile	  
structure.	   Nonetheless,	   an	   increase	   in	   the	   size	   of	   the	   ester	  
group	  ultimately	  led	  to	  a	  loss	  in	  enantioselectivities.	  	  
	   The	  Friedel-­‐Crafts	  alkylation	  –	  addition	  of	  a	  heteroaromatic	  
nucleophile	   to	   an	   activated	   electrophile	   –	   also	   met	   a	   frank	  
success	   in	   DNA-­‐hybrid	   catalysis.	   Interestingly,	   the	   reaction	  
typically	   requires	   the	   absence	   of	  water,	  which	   truly	  makes	   it	  
challenging	   to	   adapt	   to	   oligonucleotide-­‐mediated	   catalysis.	  
Nevertheless,	   several	   examples	   proved	   that	   the	   use	   of	   Lewis	  
Scheme 7. Michael additions on acylimidazoles
R1 = Ph, NuH = CH2(CO2Me)2 
L11 [up to (−) 80% ee]

















MOPS (pH 6.5), 5 °C4 15, 16 or 1712, 13 or 14
15a R1 = Ph [ee = (−) 91%]
15b R1 = p-MeOPh [ee = (+) 86%]
15c R1 = p-ClPh [ee = (+) 90%]
15d R1 = o-BrPh [ee = (−) 99%]
15e R1 = 2-furanyl [ee = (+) 86%]
15f R1 = Me [ee = (+) 58%]
16a R1 = Me, R2 = CN [ee = (+) 36%]
16b R1 = Ph, R2 = CN [ee = (+) 68%]
16c R1 = p-MeOPh, R2 = CN [ee = (+) 64%]
16d R1 = Ph, R2 = CO2Me [ee = (+) 71%]
16e R1 = p-MeOPh, R2 = CO2Me [ee = (+) 84%]
16f R1 = Ph, R2 = CO2Et [ee = (+) 64%]
16g R1 = Ph, R2 = CO2i-Pr [ee = (+) 63%]
17a R1 =  Ph [ee = (−) 85%]
17b R1 = p-MeOPh [ee = (+) 82%]
17c R1 = p-ClPh [ee = (+) 85%]
17d R1 = o-BrPh [ee = (−) 94%]
17e R1 = 2-furanyl [ee = (+) 87%]
17f R1 = Me [ee = (+) 62%]
NuH = MeNO2NuH = CH2(CO2Me)2 NuH = CH2(CN)R2
	  
	  
acids	  as	  catalysts	  could	   increase	  the	  tolerance	  of	  the	  reaction	  
for	   aqueous	  media.44	   The	   first	   enantioselective	   Friedel-­‐Crafts	  
alkylation	   with	   alkenes	   was	   achieved	   with	   a	   copper(II)	  
complex.45	   In	   a	   similar	   approach	   to	   the	   Diels-­‐Alder	   reaction,	  
Roelfes	   and	   Feringa	   were	   able	   to	   develop	   a	   highly	  
enantioselective	  Friedel-­‐Crafts	  alkylation	  using	  α,β-­‐unsaturated	  
2-­‐acyl	   imidazoles	   4	   and	   diversely	   substituted	   indoles	   18	  
(Scheme	  8).46	   After	   screening	   a	   variety	   of	   ligands,	   the	   groove	  
binding	   dmbpy	   (L12)	   led	   to	   the	   best	   results,	   with	   full	  
conversions	   and	   up	   to	   83%	   ee.	   The	   reaction	   proved	   to	   be	  
compatible	   with	   a	   wide	   variety	   of	   indoles	   albeit	   aryl-­‐
substituted	   α,β-­‐unsaturated	   2-­‐acyl	   imidazoles	   showcased	  
lower	   reactivities	   than	   their	   alkyl	   analogues.	   By	   analogy	  with	  
the	   Diels-­‐Alder	   reaction,	   a	   strong	   influence	   of	   the	   sequence	  
was	   observed;	  while	   AT-­‐rich	   sequences	   lead	   to	   disappointing	  
results,	   GC-­‐centered	   short	   oligonucleotides	   afforded	   the	   best	  
ees.	   A	   complete	   scope	   of	   the	   reaction	   was	   conducted	   with	  
d(TCAGGGCCCTGA)2	   and	   allowed	   good	   selectivities	   ranging	  
from	  69%	  to	  93%	  ee	  (Scheme	  8).	  Interestingly,	  this	  exact	  same	  




	   In	   a	   kinetic	   study	   around	   the	   Friedel-­‐Crafts	   alkylation	   and	  
the	  Michael	   addition,	   the	   data	  made	   evident	   that	  DNA,	   once	  
again,	   increased	   the	   reactivity.47	   A	   30-­‐fold	   increase	   in	   the	  
reaction	   rate	   was	   indeed	  measured	   in	   the	   presence	   of	   DNA.	  
Yet	   surprisingly,	   the	   value	   of	   the	   constant	   characterizing	   the	  
association	   between	   DNA	   and	   the	  metallic	   co-­‐factor	   showed	  
that	   only	   16%	   of	   the	   complex	   was	   bound	   to	   the	   duplex.	  
Nevertheless,	   an	   excellent	   selectivity	   was	   observed,	   which	  
confirmed	   that	   the	   reaction	   rate	   was	   increased	   by	   the	  
presence	   of	   the	   DNA,	   as	   an	   unbound	   free	   catalyst	   would	  
catalyse	  the	  reaction	  in	  a	  racemic	  fashion.	  In	  other	  words,	  the	  
DNA-­‐bound	  catalyst	  is	  solely	  responsible	  of	  the	  selectivity.	  
	   The	  co-­‐solvent	  compatibility	  was	  also	  studied	  and	  showed	  
a	   satisfying	   tolerance	   of	   the	   reaction	   to	   various	   organic	  
solvents,35	  with	  this	  time	  a	  decrease	  of	  the	  selectivity	  beyond	  
10%	   v/v.	   Attempts	   to	   increase	   the	   ees	   by	   lowering	   the	  
temperature	  was	  also	  shown	  possible	  with	  co-­‐solvents	  such	  as	  
MeOH,	  EtOH,	  DMF,	  DMSO	  and	  1,4-­‐dioxane.	  Indeed,	  at	  4	  °C	  and	  
–18	  °C,	   the	   enantioselectivity	   of	   the	   Friedel-­‐Crafts	   alkylation	  
increased	   up	   to	   90%	   with	   every	   solvent	   except	   EtOH	   and	  	  
1,4-­‐dioxane,	   albeit	   with	   a	   mild	   decrease	   in	   the	   conversion.	  
These	  results	  are	  particularly	  interesting	  as	  they	  represent	  the	  
highest	   levels	   of	   enantioselectivity	   ever	   achieved	   so	   far	   for	  
Friedel-­‐Crafts	  alkylations	  with	  DNA.46	  
	   An	   intramolecular	   Friedel-­‐Crafts	   alkylation	   was	   also	  
reported	   by	   Sugiyama	   and	   co-­‐workers	   (Scheme	   9).48	   The	  
reaction	   involved	   the	   cyclization	   of	   diversely	   functionalized	  
fused	   indole-­‐imidazoles	  20	   catalysed	  by	  Cu(II)	   complex	   in	   the	  
presence	  of	  st-­‐DNA	  or	  selected	  sequences,	  with	  up	  to	  82%	  ee	  
obtained	   using	   d(TGTGTGCACACA)2.	   The	   sequence	  
dependency	   was	   this	   time	   proven	   to	   differ	   from	   the	   classic	  
intermolecular	   approach.	   Although	   the	   difference	   can	   be	  
attributed	   to	   the	   reaction	   itself,	   the	   use	   of	   an	   intercalating	  
ligand,	   5,6-­‐dimethylphenanthroline	   L17,	   instead	   of	   the	   usual	  
L12	  used	  in	  the	  groove	  binding	  strategy	  may	  be	  the	  reason	  of	  
such	   disparities.	   Once	   again	   this	   example	   confirms	   the	   clear	  
influences	   of	   the	   binding	   mode	   topology,	   logically	   differing	  
from	   one	   co-­‐factor	   to	   another,	   on	   the	   chirality	   transfer.	   This	  
latter	   characteristic	  was	   recently	   investigated	   theoretically	  by	  
Morokuma	  and	  co-­‐workers.	  A	  detailed	  analysis	  of	  the	  possible	  
interactions	   between	   the	   metallic	   co-­‐factor	   and	   a	   chosen	  
sequence	   allowed	   to	   enlighten	   the	   most	   favoured	  





Recently,	   Roelfes	   and	   co-­‐workers	   enriched	   the	   scope	   of	   the	  
Friedel-­‐Crafts	   alkylation	   using	   2-­‐methyl-­‐1-­‐(thiazol-­‐2-­‐yl)prop-­‐2-­‐
en-­‐1-­‐one	   as	   electrophile.50	   This	   rather	   interesting	   structural	  
change	   allowed	   to	   obtain	   a	   tertiary	   carbon	   center	   at	   the	  
β	  position	   upon	   addition	   of	   various	   indoles	   and	   and	  
subsequent	   reprotonation.	   L12	   still	   afforded	   the	   best	   results	  
with	  ees	  as	  high	  as	  84%.	  Interestingly,	  the	  system	  was	  proven	  
to	   afford	   the	  highest	   rate	   increase	   ever	   reported	   (up	   to	   990-­‐
fold	   acceleration).	   The	   study	   indeed	   revealed	   that	   DNA	   is	  
generally	   behaving	   like	   a	   micelle,	   binding	   the	   different	  
substrates	   and	   therefore	   increasing	   the	   effective	  
concentration	   in	   the	  vicinity	  of	   the	  oligonucleotide.	  However,	  
the	  authors	  insisted	  on	  the	  fact	  that	  the	  binding	  affinity	  had	  to	  
remain	   moderate	   in	   order	   to	   avoid	   any	   kind	   of	   inhibition	  
caused	  by	  a	  high	  affinity	  of	   the	   reactants	  or	  products	   for	   the	  
scaffold.	   Once	   again,	   this	   study	   clearly	   underlines	   the	   crucial	  
importance	   of	   the	   dynamics	   and	   structural	   assets	   of	   the	   bio-­‐
hybrid	   catalyst	   for	   both	   the	   enantioselectivity	   and	   the	  
reactivity.	  
	   Our	   group	   recently	   took	   interest	   in	   the	   use	   of	   copper-­‐
catalysed	   Friedel-­‐Crafts	   alkylations	   to	   translate	  	  
DNA-­‐mediated	   catalysis,	   and	   especially	   the	   groove	   binding	  
strategy,	  to	  RNA.51	  In	  an	  approach	  consisting	  in	  using	  selected	  
short	  double	  stranded	  RNA	  sequences	  as	  chiral	  templates,	  we	  
observed	   good	   reactivities	   albeit	   only	   moderate	   selectivities	  
[up	   to	   (+)	  54%	  ee].	   Although	   a	   non-­‐negligible	   decrease	   in	   the	  
ee	   was	   observed	   when	   comparing	   the	   results	   to	   the	   ones	  
obtained	   with	   DNA,	   this	   study	   underlined	   the	   possibility	   of	  
using	  short	  RNA	  sequences	  in	  asymmetric	  catalysis	  rather	  than	  
natural	   or	   synthetic	   ribozymes.52-­‐63	   The	   latter	   were	   indeed	  
used	   in	   a	   wide	   panel	   of	   reactions,	   but	   their	   structure	   and	  
topology	   make	   them	   difficult	   to	   access	   synthetically.	   On	   the	  
other	   hand,	   the	   results	   made	   clear	   that	   canonical	   double	  
stranded	  architectures	  could	  lead	  to	  encouraging	  selectivities.	  
Scheme 8.  Friedel-Crafts alkylation between α,β-unsatured acylimidazoles and 
indoles
st-DNA [ee = (+) 83% ee]
d(ATATATATATAT)2 [ee = (+) 35% ee]
 d(TCAGTGCACTGA)2 [ee = (+) 63% ee]























19a R1 = Me, R2 = H, R3 = H, R4 = MeO [ee = (+) 83%]
19b R1 = Me, R2 = H, R3 = H, R4 = H [ee = (+) 72%]
19c R1 = Me, R2 = H, R3 = H, R4 = Cl [ee = (+) 72%]
19d R1 = Me, R2 = Me, R3 = H, R4 = H [ee = (−) 79%]
19e R1 = Me, R2 = H, R3 = Me, R4 = H [ee = (−) 81%]
19f R1 = Ph, R2 = H, R3 = Me, R4 = H [ee = (+) 75%]
19g R1 = o-BrPh, R2 = Me, R3 = H, R4 = H [ee = (+) 79%]
19h R1 = p-MeOPh, R2 = H, R3 = H, R4 = MeO [ee = (+) 69%]
19i  R1 = p-ClPh, R2 = H, R3 = H, R4 = MeO [ee = (+) 79%]
19j  R1 = n-Pentyl, R2 = Me, R3 = H, R4 = H [ee = (+) 76%]
R3
R3
R1 =  Me, R2 =  R3 = H, R4 = MeO
19
Scheme 9. Intramolecular Friedel-Crafts alkylation
Cu(II), st-DNA

















21a R1 = H, R2 = H [ee = (+) 71%]
21b R1 = H, R2 = F [ee = (+) 70%]
21c R1 = H, R2 = Br [ee = (+) 77%]
21d R1 = H, R2 = OMe [ee = (+) 78%]
21e R1 = Me, R2 = H [ee = (+) 7%]
21f R1 = Bn, R2 = H [ee = (+) 4%]
N N
Me Me
R1 =  H, R2 =  OMe
st-DNA [ee = (+) 78% ee]
 d(TGTGTGCACACA)2 [ee = (+) 82% ee]
	  
	  
	   Several	   other	   transformations	  were	   developed	   by	  making	  
use	   of	   the	   groove	   binding	   strategy	   and	   confirmed	   the	  
applicability	  of	  this	  mode	  of	  interaction.	  Toru	  and	  co-­‐workers,	  
for	   instance,	   reported	   an	   early	   study	   on	   an	   enantioselective	  
DNA-­‐mediated	   fluorination	   reaction	   (Scheme	   10).64	   Although	  
this	   investigation	   has	   often	   been	   overshadowed	   by	   the	  
simultaneous	   development	   of	   DNA-­‐mediated	   C-­‐C	   bond	  
forming	  reactions	  by	  Roelfes	  and	  Feringa,	  it	  still	  represents	  the	  
only	  example	  of	  C-­‐F	  bond	  forming	  reaction	  in	  the	  domain.	  The	  
authors	   were	   able	   to	   catalyse	   the	   fluorination	   of	   indanone	  
carboxylates	  22	  with	  Selectfluor™	  23	  with	   the	  groove	  binding	  
complex	   Cu(L12).	   The	   mechanism	   proceeds	   via	   an	   enolate	  
intermediate,	   which	   adopts	   a	   transition	   state	   resembling	   a	  
distorted	   square	   planar	   conformation,	   in	   which	   the	   Cu(II)	  
coordinates	  to	  the	  ligand	  and	  also	  chelates	  to	  the	  two	  carbonyl	  
oxygen	   atoms.	   The	   efficacy	   of	   L12	   was	   rapidly	   observed	   and	  
led	   to	   a	   wide	   range	   of	   enantioselectivities,	   from	   a	  moderate	  
(+)	  16%	   ee	   to	   a	   comparatively	   impressive	   (+)	   74%	   ee,	  




	   Roughly	   at	   the	   same	   time,	   Roelfes	   and	   co-­‐workers	   took	  
interest	   in	   yet	   another	   reaction:	   the	   DNA-­‐based	   hydrolytic	  
kinetic	   resolution	   of	   pyridyloxiranes	   25	   (Scheme	  11).65	  
Although	  the	  selectivities	  remained	  low	  (up	  to	  63%	  ee	  at	  74%	  
conversion,	  s	  =	  2.7),	  this	  study	  confirmed	  the	  potency	  of	  DNA	  




	   As	  we	  clearly	  stated	  all	  along	  this	  section,	  the	  minor	  groove	  
binding	  anchorage	  strategy	  allowed	  the	  development	  of	  highly	  
enantioselective	  transformations.	   It	   is	  however	  worth	  to	  note	  
that	   the	   precise	   characterization	   of	   the	   interaction	   existing	  
between	   bipyridine-­‐type	   ligands	   and	   the	   double	   strand	   has	  
only	   been	   reported	   in	   2015,	   nearly	   ten	   years	   after	   their	  
introduction	   in	   DNA-­‐mediated	   catalysis.18	   Consequently,	   the	  
whole	  development	  of	   the	   strategy	  was	   conducted	  without	  a	  
clear	  view	  of	  its	  intrinsic	  mechanism.	  	  
	   Lately,	   our	   group	  opted	   for	   a	  more	   rational	  minor	   groove	  
anchorage	  approach.20	  Indeed,	  we	  envisaged	  the	  use	  of	  a	  new	  
class	   of	   copper(II)-­‐ligands	   (L13-­‐16)	   based	   on	   the	   well-­‐known	  
minor	  groove	  binder	  Hoechst	  33258.	  The	  idea	  was	  to	  develop	  
sequence-­‐specific	   targeted	   reactions	   (Scheme	   12).	   A	   set	   of	  
diversely	   substituted	   Hoechst	   33258-­‐derived	   ligands	   were	  
therefore	   prepared	   before	   a	   complete	   spectroscopic	  
characterization	   of	   the	   interaction	   between	   the	   ligands	   and	  
selected	   oligonucleotides,	   followed	   by	   a	   molecular	   docking	  
study	   was	   undertaken	   in	   order	   to	   ensure	   the	   minor	   groove	  
binding	   anchorage	   mode.	   The	   screening	   of	   the	   ligands	   over	  
various	  sequences	  allowed	  a	  clear	  determination	  of	   the	  short	  
binding	  sites	  preferentially	  selected	  by	  the	  ligands.	  Their	  use	  in	  
copper(II)-­‐catalysed	   Friedel-­‐Crafts	   alkylations	   showed	   an	  
apparent	   correlation	   between	   their	   selectivity	   for	   the	  
sequences	   and	   the	   enantioselectivity	   outcome.	   Although	   the	  
selectivities	  remained	  rather	  moderate	  [up	  to	  (+)	  47%	  ee],	  the	  
use	   of	   Hoechst-­‐derived	   ligands	   and	   their	   sequence	   specific	  






3. Covalent	  approach	  
The	   supramolecular	   approach	   in	   DNA-­‐based	   asymmetric	  
catalysis	  has	  encountered	  a	  rapid	  success.	  As	  we	  stated	  in	  the	  
previous	  section,	  both	  intercalation	  and	  groove	  binding	  modes	  
allowed	   to	   unveil	   the	   power	   of	   oligonucleotides	   as	   easily	  
accessible	  chiral	  scaffolds	  with	  seducing	  synthetic	  applications.	  
But	   there	   is	   somehow	   a	   certain	   lack	   of	   completeness	   in	   this	  
approach.	   Indeed,	   numerous	   studies	   have	   pointed	   out	   the	  
influence	  of	  the	  sequence	  (length,	  nature	  or	  base	  content)	  on	  
the	   selectivity	   and	   offered	   a	   first	   insight	   on	   the	   mechanism	  
occurring	   during	   the	   chirality	   transfer.	   However,	   none	   of	   the	  
intercalating	   or	   groove	   binding	   ligands	   used	   in	   the	  
supramolecular	   approach	   present	   a	   sufficient	   affinity	   for	  
specific	   sites	   to	   ensure	   a	   well	   defined	   positioning	   of	   the	  
metallic	   co-­‐factor.	   To	   address	   this	   site-­‐selectivity	   matter,	   a	  
more	  pragmatic	  or	  perhaps	  biased	  approach	  was	  to	  covalently	  
attach	   the	   ligand	   onto	   a	   specific	   position	   and	   therefore	  
develop	   oligonucleotide-­‐conjugates	   for	   asymmetric	   catalysis	  









L5, L8, L11 or L12
Cu(II), st-DNA






Scheme 10.  Fluoration of indanones
R1 = Me, R2 = H
22 23
24a R1 = Me, R2 = H [ee = (+) 47%]
24b R1 = Bn, R2 = H [ee = (+) 24%]
24c R1 = Et, R2 = H [ee = (+) 54%]
24d R1 = i-Pr, R2 = H [ee = (+) 70%]
24e R1 = t-Bu, R2 = H [ee = (+) 74%] 
24f R1 = Me, R2 = Br [ee = (+) 22%]
Scope (L12)
L5 [up to (+) 12% ee] 
L8 [up to (+) 14% ee] 
L11 [up to (+) 28% ee] 
L12 [up to (+) 47% ee]
.
L4,  L11 or L12
Cu(II), st-DNA
MOPS (pH 6.5), 5 °C
26a R1 = H [up to (+) 10% ee, s = 1.5]
26b R1 = Ph (trans) [up to (+) 63% ee, s = 2.7]
26c R1 = Ph (cis) [up to (+) 4% ee, s = 1.2]
26d R1 = p-MeOPh [up to (+) 7% ee, s = 1.2]
Scheme 11. Kinetic resolution of epoxides
R1 = Ph (trans)
L4 [up to (+) 12% ee, s = 1.1] 
L11 [up to (+) 21% ee, s = 1.9] 










Scheme 12.  Friedel-Crafts alkylation using Hoechst-derived ligands L13-16
(+) 29% ee (Ka = 3.24 106 M-1)
L14
ct-DNA
5'-d(CGTATACGTTTTCGTATACG)-3' (−) 19% ee
Oligonucleotide








































	   	  A	  covalent	  attachment	  allows	  the	  enforced	  generation	  of	  a	  
chiral	   micro-­‐environment,	   where	   the	   ligand	   is	   constrained	   in	  
the	   helix	   or	   in	   its	   closest	   vicinity.	   Also,	   a	   covalent	   ligation	  
strategy	  offers	   the	  possibility	   to	   control	   the	   exact	   location	  of	  
the	  ligand	  and	  therefore,	  study	  the	  influence	  of	  the	  flanking	  or	  
opposite	   bases	   by	   varying	   its	   position	   in	   the	   oligonucleotide	  
(ON)	  sequence.	  Although	  the	  process	  of	  covalent	  anchorage	  to	  
oligonucleotide	   can	   be	   seen	   as	   more	   time-­‐consuming	   or	  
complex,	   numerous	   methods	   have	   been	   developed	   to	  
envisage	  direct	   and	  easy	  modifications	  of	   oligonucleotides.	   66	  
This	   approach	   was	   eventually	   applied	   to	   various	   synthetic	  
transformations,	   which	   will	   be	   reported	   in	   the	   following	  
sections	  according	  to	  the	  type	  of	  metal	  used.67-­‐72	  
	  
3.1 Cu(II)-­‐catalysis	  
The	  excellent	  results	  reported	  with	  copper-­‐catalysed	  reactions	  
using	   the	   supramolecular	   assembly	   strategy	   encouraged	  
several	   groups	   to	   turn	   their	   attention	   on	   the	   use	   of	   ON	  
conjugates	   in	   asymmetric	   catalysis.	   Roelfes	   and	   co-­‐workers	  
first	   developed	   the	   concept	  with	  Diels-­‐Alder	   cycloadditions,73	  
using	   a	   ON	   conjugate	   formed	   by	   the	   covalent	   assembly	  
between	   an	   NHS-­‐activated	   bypiridine	   ester	   and	   5’-­‐amino-­‐
modified	  ON	  27a-­‐b	  (Scheme	  14).	  This	  ligand-­‐bearing	  ON	  strand	  
was	   then	   hybridized	   by	   combination	  with	   another	  ON	   strand	  
(ON2)	  and	  a	  template	  strand	  complementary	  to	  both,	  to	  afford	  
the	   duplexes	   28a-­‐b,	   positioning	   the	   transition	   metal	   in	  
between	   the	  ON1	   and	  ON2	   termini.	   Using	   this	   three-­‐partner	  
strategy,	   the	   environment	   surrounding	   the	  metallic	   co-­‐factor	  
could	  be	  modulated	  by	  simply	  changing	  ON2	  and	  the	  template	  
strand.	  Using	  the	  main	  advantage	  of	  covalent	  assembly,	  ie	  the	  
specific	   positioning	   of	   the	   Cu(II)/bipyridine-­‐derived	   ligand	  
complex	   on	   the	   ON,	   the	   authors	   reported	   extremely	  
encouraging	   enantioselectivities,	   with	   ee	   up	   to	   89%	   using	   a	  
central	  positioning	  of	  the	  co-­‐factor,	  G	  as	  flanking	  bases,	  and	  a	  
complementary	   template.	   This	   selectivity	   could	   be	   increased	  
to	   93%	   using	   a	   shorter	   spacer	   (28b)	   showcasing	   the	  





	   Another	   strategy	  was	   reported	   by	   the	   same	   group	  with	   a	  
covalent	   anchorage	   of	   a	   cisplatin-­‐derived	   copper	   ligand.74	  
Although	  the	  type	  of	  attachment	  truly	  differs,	  the	  approach	  is	  
structurally	  close	  to	  the	  previous	  one	  as	  it	   involves	  a	  covalent	  
bond	  between	  the	  cisplatin	  moiety	  and	  the	  bases	  to	  ensure	  a	  
stable	  anchorage	  to	  the	  duplex	  and	  the	  dangling	  ligand	  is	  free	  
to	   interact	  with	   the	   duplex.	  Nevertheless,	   it	   is	  worth	   to	   note	  
that	   although	   the	   cisplatin	   anchorage	   is	   very	   robust	   and	  
represents	   a	   clever	   alternative	   to	   the	   supramolecular	  
anchorage,	   it	   is	   unfortunately	   non-­‐selective.	   The	   catalytic	  
efficacy	  of	  the	  cisplatin	  anchorage	  was	  tested	  with	  st-­‐DNA	  on	  
the	  Diels-­‐Alder	   cycloaddition	   and	   the	   Friedel-­‐Crafts	   alkylation	  
affording	  good	  selectivities	  (up	  to	  73	  and	  64%	  ee	  respectively)	  
though	   lower	   than	   those	   obtained	   with	   the	   supramolecular	  
approach.	  Nevertheless,	   the	  major	   advance	   of	   the	   study	  was	  
truly	  the	  possibility	  to	  covalently	  attach	  a	  metallic	  co-­‐factor	  to	  
a	   DNA	   scaffold	   and	   ensure	   its	   complete	   non-­‐lability.	   Such	  





	   More	   recently,	   Sugiyama	   and	   co-­‐workers	   developed	  
another	   type	   of	   covalent	   anchorage	   consisting	   in	   the	   double	  
attachment	  of	  a	  bipyridine	  derivative	  in	  13-­‐mer	  sequences	  as	  a	  
base	   surrogate.	   These	   bioconjugates	  were	   eventually	   used	   in	  
an	   intramolecular	   Friedel-­‐Crafts	   alkylation	   after	   hybridization	  
(Scheme	   15).75	   An	   interesting	   screening	   of	   the	   counter	   base	  
showed	  that	   the	  use	  of	  pyrimidines	   (C	  and	  T),	   smaller	   in	  size,	  
was	   more	   favourable	   than	   the	   use	   of	   purines	   (A	   and	   G).	  
Flanking	  bases	  showed	  a	  great	  influence	  as	  the	  use	  of	  G	  and	  C	  
lead	   to	   a	   high	   selectivity	   (up	   to	   84%	   ee)	   whereas	   A	   and	   T	  
caused	   a	   dramatic	   decrease	   in	   the	   ee.	   The	   authors	   also	  
conducted	   a	   complete	   model	   study	   to	   rationalise	   the	  
oligonucleotide	   conjugates	   used	   in	   catalysis.	   They	   confirmed	  
that	   the	   use	   of	   cytosine	   as	   the	   nucleic	   base	   facing	   the	  
modification	  lead	  to	  the	  highest	  selectivities.	  
	   The	   direct	   incorporation	   of	   the	   metallic	   co-­‐factor	   in	   the	  
heart	  of	   the	  duplex	  was	  also	   investigated	  with	  other	   types	  of	  
ligands.	   Hence,	   in	   2015,	   Carrell’s	   group	   envisioned	   the	  
introduction	  of	  pyrazoles	  or	   salen	  as	  metal	   coordinating	  base	  
pair	   surrogates	   to	   form	  a	   duplex	   stabilized	  by	   several	   copper	  
complexations.76	   The	   coordination	   was	   studied	   with	   CD	   and	  
UV-­‐vis	   spectroscopy,	   which	   interestingly	   revealed	   the	  
preference	   of	   the	  metallic	   center	   for	   pyrazole	   base	   pairs.	   An	  
impressive	   increase	   in	   stability	   was	   observed	   upon	   copper	  
addition,	  with	  melting	   temperatures	   (Tm)	   rising	   from	  38	  °C	   to	  
70	  °C	   after	   only	   one	   ionic	   coordination.	   These	   different	  
structures	   were	   later	   tested	   in	   the	   context	   of	   asymmetric	  







Scheme 13.  Covalent attachment strategy








27a (n = 6)










MOPS (pH 6.5), 5 °C
Cu(II), cyclopentadiene 2
 ON conjugates 28a-bN
1
with 28a [up to (+) 89% ee]
with 28b [up to (+) 93% ee]
Scheme 14. Single bipyridine attachment to ON, Diels-Alder cycloadditions
28a (n = 6)
































X = intrastrand bipyridine ligand
Scheme 15. Double bipyridine attachment to ON, intramolecular Friedel-Crafts 
alkylations
29a (n = 3)
Cu(II), ON conjugate














acceleration	  was	  clearly	  observed	  but	  only	  modest	  selectivities	  
were	  obtained	  (up	  to	  39%	  ee).	  Interestingly,	  a	  rather	  counter-­‐
intuitive	   pH	   influence	   was	   unveiled	   with	   a	   progressive	  
decrease	   in	   both	   selectivity	   and	   reactivity	   upon	   medium	  
basification	   although	   the	   copper	   complexation	   is	   logically	  
eased	  at	  higher	  pH.	  Other	  parameters,	  such	  as	  the	  variation	  of	  
the	   duplex	   structure	   also	   need	   to	   be	   taken	   into	   account,	  
nonetheless,	  this	  system	  did	  prove	  its	  efficacy	  in	  catalysis.	  	   	  
	   In	   a	   recent	   study,	   Park	   et	   al.	   promoted	   the	   concept	   of	  
ligandoside	   approach,	   with	   the	   design	   of	   ligand-­‐free	  
catalysis.77	  They	  envisioned	  the	  use	  of	  hybrid	  cytosine/flexible	  
linkers	   base	   pairs	   as	   coordination	   sites	   for	   copper(II)	   and	  
observed	   excellent	   results	   in	   catalysis	   (Scheme	   16).	   With	   a	  
facing	   glycol	   base	   surrogate	   (from	   30a),	   the	   surrounding	  
flanking	  bases	  proved	  to	  have	  a	  non-­‐negligible	  influence	  on	  the	  
selectivity	   of	   the	   site.	   Using	   the	   Diels-­‐Alder	   cycloaddition	   as	  
the	  model	   reaction,	  a	  wide	  range	  of	  ees	  were	  obtained,	   from	  
(−)	   13%	   using	   G	   as	   flanking	   bases	   to	   (−)	   94%	   with	   T	   and	   A	  
surrounding	   the	   spacer.	   This	   latter	   result	   was	   increased	   to	  
(−)	  97%	   when	   the	   linker	   was	   replaced	   by	   a	   propyl	   base	  
surrogate	   (from	   30c).	   Relatively	   close	   selectivities	   were	  
observed	   when	   a	   scope	   of	   the	   reaction	   was	   conducted,	  






3.2	  Pd	  and	  Ir-­‐catalysed	  allylic	  aminations	  	  
The	  covalent	  approach	  also	  allowed	  to	  use	  new	  metals	  in	  DNA-­‐
mediated	   catalysis.	   The	   easy	  modification	   of	   oligonucleotides	  
can	   indeed	   lead	   to	   the	   covalent	   attachment	   of	   non-­‐DNA	  
binding	   ligands	   and	   ensures	   their	   positioning	   in	   the	   close	  
proximity	   of	   the	   duplex.	   The	   palladium-­‐catalysed	   allylic	  
amination	  was	   the	   first	   example	   of	   covalent	   assembly	   of	   the	  
ligand	   to	   ON	   in	   DNA-­‐based	   catalysis	   (Scheme	   17).78	   The	   ON	  
conjugate	  catalyst	  was	  obtained	  by	  functionalization	  of	  readily	  
available	   5-­‐iodo-­‐2’-­‐deoxyuridine	   (IdU)-­‐containing	   sequence	   to	  
form	  the	  corresponding	  diphenylphosphine	  derivative	  34.	  The	  
palladium	  bio-­‐inorganic	  complexes	  were	  then	  generated	  using	  
[Pd(allyl)Cl2]	   after	   duplex	   formation	   to	   catalyse	   the	   allylic	  
amination	   between	   benzylamine	   31	   and	   1,3-­‐diphenyl-­‐2-­‐
propenyl	   acetate	   32	   in	   THF	   (Scheme	   17).	   High	   ees	   were	  
reported	   (up	   to	   80%)	   as	   well	   as	   an	   interesting	   solvent-­‐
dependent	   inversion	   of	   selectivity.	   Nevertheless,	   no	   real	  
rationalization	  was	  suggested.	  
	   A	   rather	   similar	   approach	  was	   later	   envisaged	   by	   Jäschke	  
and	   co-­‐workers	   for	   the	   DNA-­‐mediated	   Ir(I)-­‐catalysed	   allylic	  
amination	   of	   allyl	   acetate.79	   The	   authors	   developed	   a	  	  
ON	   conjugate-­‐diene-­‐iridium(I)	   complex	   and	   evaluated	   its	  
catalytic	   activity	   (Scheme	   18).	   The	   ON	   strand	   was	  
functionalised	   by	   a	   diene	   ligand	   and	   then	   hybridized	   with	   a	  
complementary	  DNA	  or	  RNA	  strand.	  Both	  isomers	  of	  the	  chiral	  
diene	   ligand	  were	  used	   in	  order	   to	  access	  either	  enantiomer.	  
The	   functionalization	   was	   possible	   using	   commercially	  
available	   4-­‐triazolyl-­‐deoxyuridine.	   Post-­‐synthetic	   conjugation	  
with	   either	   35	   or	   36	   lead	   to	   the	   formation	   of	   the	   Ir(I)	  






	   Interestingly,	   the	   non-­‐hybridized	   ON	   conjugates	   afforded	  
the	   same	   ee	   as	   the	   free	   ligand	   37	   (up	   to	   23%	   ee),	   but	   upon	  
addition	   of	   the	   complementary	   strand,	   the	   selectivity	  
dramatically	   changed,	   with	   a	   general	   inversion	   in	   the	   ees,	  
therefore	   proving	   that	   the	   duplex	   was	   sterically	   constraining	  
the	  substrates.	  Unfortunately,	  only	  moderate	  chiral	  inductions	  
were	   reported,	   the	   best	   ee	   being	   (−)	   27%	   using	   RNA	   as	   the	  
complementary	  sequence.	  Nevertheless,	  the	  striking	  inversion	  
of	   selectivity	   between	   single	   and	   double	   strands	   once	   again	  
proved	   that	   DNA	   and	   RNA	   could	   truly	   act	   as	   templates	   for	  
asymmetric	  catalysis.	  
	   These	   last	  examples	   showcased	   several	   advantages	  of	  ON	  
conjugates	   in	   catalysis,	   in	   particular	   the	   complete	   control	   of	  
the	   positioning	   of	   the	   metallic	   co-­‐factor.	   Moreover,	   the	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Scheme 17. Allylic amination of 1,3-diphenyl-2-propenyle acetate by benzylamine
*
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flanking	   bases	   can	   be	   easily	   evaluated	   which	   is	   a	   clear	  
advantage	  over	  the	  supramoecular	  approach.	  
4. Non-­‐canonical	  DNA	  structures	  
The	  previous	  sections	  demonstrated	  that	  DNA-­‐duplexes	  could	  
act	  as	  extremely	  efficient	  chiral	  templates	  for	  various	  types	  of	  
metal-­‐catalysed	   transformations.	   Although	   the	   duplex	  
structure	  was	  established	  to	  be	  compulsory	  to	  attain	  satisfying	  
levels	   of	   selectivity,	   single-­‐stranded	  DNA	   catalysis	   did	   lead	   to	  
some	   enantioselectivity.34,46,76,79	   The	   chirality	   of	   the	   duplex	   is	  
actually	   insured	   by	   the	   ribose	   itself,	   which	   leads	   to	   the	  
conclusion	   that	   any	   oligonucleotide-­‐based	   secondary	   or	  
tertiary	   structure,	   natural	   or	   synthetic,	   is	   chiral	   and	   can	  
therefore	  be	  used	  in	  asymmetric	  catalysis.	  Considerable	  efforts	  
have	   recently	   been	   devoted	   to	   the	   development	   and	  
understanding	   of	   non-­‐canonical	   scaffolds	   for	   catalysis,	   and	  
very	   diverse	   applications	   were	   identified.	   Considering	   the	  
great	  manoeuvrability	  of	  oligonucleotides,	  these	  structures	  are	  
countless	   but	   a	   few	   were	   actually	   investigated.	   Natural	  
assemblies,	  such	  as	  G-­‐quadruplex,	  or	  synthetic,	  such	  as	  mirror-­‐
image	   or	   supported-­‐DNA,	   led	   to	   very	   interesting	   results	   and	  
therefore	  deserve	  careful	  examination.	  
	  
4.1	  G-­‐quadruplex	  DNA	  in	  asymmetric	  catalysis	  
Unlike	   hybrids,	   such	   as	   DNA-­‐RNA	   duplexes,	   which	   were	   not	  
intensively	   evaluated,79	   G-­‐quadruplexes	   recently	   met	   a	  
growing	   success	   in	   catalysis,	   after	   being	   first	   wrongly	  
considered	  as	  simple	  curiosities.	  G-­‐quadruplex	  DNA	  (G4DNA)	  is	  
one	  of	  the	  alternative	  conformation	  guanine-­‐rich	  DNA	  strands	  
can	   adopt.80	   The	   structure	   consists	   of	   the	   Hoogsteen	   base	  
pairing	   of	   four	   guanines	   on	   a	   strand	   to	   form	   a	   tetramer,81	  
while	   the	   rest	   of	   the	   strand	   loops	   round,	   forming	   other	  
tetramers	   stacking	   above	   the	   latter.	   G4DNA	   have	   been	  
identified	   in	   G-­‐rich	   eukaryotic	   telomeres	   (h-­‐tel)	   but	   also	   in	  
non-­‐telomeric	  DNA	  regions	  (c-­‐myc).	  According	  to	  the	  base	  pair	  
sequence,	   strand	   length	   and	   species	   with	   which	   it	   is	   in	  
solution,	   G4DNA	   can	   adopt	   different	   topologies:	   parallel,	  
antiparallel	   (2+2)	  or	  hybrid	   (3+1)	   (Scheme	  19).80	  This	  has	   lead	  




	   The	  first	  example	  of	  a	  G4DNA	  used	  as	  a	  chiral	  scaffold	  was	  
reported	   by	   Moses	   and	   co-­‐workers	   with	   the	   copper(II)-­‐	  
catalysed	  Diels-­‐Alder	  reaction.82	  Using	  a	  bio-­‐inorganic	  complex	  
formed	   by	   a	   G4DNA	   scaffold	   of	   two	   different	   G-­‐quadruplex	  
forming	  sequences	  (c-­‐kit	  and	  h-­‐Tel),	  copper(II)	  and	  the	  groove	  
binding	   ligand	   L12,	   the	   authors	   reported	   excellent	   endo/exo	  
selectivities,	   up	   to	   100:0,	   but	   moderate	   enantioselectivities,	  
with	  ees	  up	  to	  (−)	  34%.	  A	  detailed	  spectroscopic	  study	  brought	  
an	   interesting	   rational	   to	   this	   selectivity.	   Indeed,	   CD	  
experiments	   made	   plain	   that	   various	   conformations	   of	   h-­‐Tel	  
were	  actually	  present	  in	  solution.	  Upon	  addition	  of	  the	  ligand,	  
negligible	   changes	   in	   CD-­‐spectra	   and	   thermal	   stabilities	  were	  
observed,	  proving	  that	  no	  conformation	  was	  actually	  favoured.	  
Two	  scenarios	  were	  therefore	  envisioned:	  catalysis	  conducted	  
both	  on	  and	  off	  the	  G4DNA	  caused	  by	  the	  low	  binding	  affinity	  
of	   the	   ligands,	   or	   the	   possibility	   that	   among	   the	   different	  
conformations	   in	   solution,	   some	   may	   disfavour	   the	   desired	  
enantioselection.	  As	  always,	  the	  heart	  of	  the	  matter	  seems	  to	  
be	  residing	  in	  the	  control	  of	  the	  interaction	  between	  the	  chiral	  
scaffold	  and	  the	  catalytically	  active	  species.	  
	   More	   recently,	   the	   group	   of	   Li,	   who	   rapidly	   became	  
prominent	   in	   the	   domain,	   came	   up	   with	   several	   concepts	  
which	  enabled	  to	  unlock	  the	  catalytic	  efficacy	  and	  applicability	  
of	  G-­‐quadruplexes.	  In	  two	  successive	  studies,	  they	  proved	  that	  
a	   ligand-­‐free	   approach	   could	   lead	   to	   interesting	   levels	   of	  
selectivity	   in	   both	   the	   Diels-­‐Alder	   cycloaddition	   and	   the	  
Friedel-­‐Crafts	   alkylation.83,84	   As	   we	   earlier	   stated	   with	   the	  
ligandoside	   approach	   in	   the	   covalent	   attachment	   strategy,	  
divalent	   cations	   chave	   a	   high	   affinity	   for	   nucleic	   acids.	   The	  
authors	   therefore	   observed	   that	   the	   h-­‐Tel	   sequence,	   in	   a	  
specific	   anti-­‐parallel	   conformation,	   could	   lead	   to	   very	  
satisfying	   enantioselectivities	   even	   in	   the	   absence	   of	   ligands.	  
Up	  to	  75%	  ee	  could	  be	  obtained	  in	  the	  Friedel-­‐Crafts	  alkylation	  
and	   74%	   ee	   in	   the	   Diels-­‐Alder	   cycloaddition,	   while	   a	   clear	  
increase	  in	  the	  reaction	  rates	  was	  observed	  in	  the	  presence	  of	  




	   The	  use	  of	  a	  higher-­‐order	  h-­‐Tel	  sequence,	  which	  contains	  a	  
greater	   amount	   of	   G-­‐quartets,	   allowed	   to	   increase	   the	  
selectivity	   (up	   to	   92%	   ee)	   and	   the	   rate	   of	   the	   Diels-­‐Alder	  
reaction.85	  Interestingly,	  the	  architecture	  of	  the	  chiral	  scaffold	  
was	   also	   proven	   to	   be	   easily	   tunable	   (Scheme	  21).	   By	   first	  
changing	  the	  sequence,	  a	  clear	  switch	  from	  the	  anti-­‐parallel	  to	  
the	  parallel	   conformation	  was	  observed	   in	  CD	  and	   correlated	  
with	   a	   partial	   inversion	   in	   the	   enantioselectivity.	   The	   same	  
type	   of	   phenomenon	  was	   detected	   upon	   gradual	   addition	   of	  
NaCl,	   KCl	   or	   PEG200,	   causing	   dramatic	   changes	   in	   the	  
conformation	  of	  the	  G4DNA.	  The	  compacity	  of	  the	  anti-­‐parallel	  
structure	   was	   reinforced	   by	   NaCl	   and	   reached	   its	   optimal	  
efficacy	   at	   50	   mM	   for	   both	   Diels-­‐Alder	   and	   Friedel-­‐Crafts	  
reactions,	  but	  a	  decrease	  in	  the	  ees	  was	  observed	  beyond	  this	  
concentration.	  KCl	  addition	  led	  to	  a	  gradual	  prominence	  of	  the	  
hybrid	   confirmation	   and	   lower	   enantioselectivities.	   As	   for	  
PEG200,	  molecular	  crowding	  led	  to	  the	  general	  appearance	  of	  
the	   parallel	   conformations,	   causing	   loss	   of	   selectivities	   in	   the	  
Friedel-­‐Crafts	  alkylation,	  but	  inversions	  in	  ees	  in	  the	  Diels-­‐Alder	  
cycloaddition	   [from	   74%	   to	   (−)	   47%].	   The	   same	   group	   later	  
reported	   the	   possibility	   to	   create	   a	   conformational	   switch	   in	  
G4DNA	   using	   chosen	   Na+/K+	   ratios.86	   They	   observed	   that	   a	  
100/0	  mM	  ratio	  undoubtedly	  leads	  to	  a	  parallel	  conformation,	  
evolving	   to	   a	   hybrid	   conformation	   at	   50/25	   mM.	   Although	  
lower	  selectivities	  were	  obtained,	  this	  switch	  could	  once	  again	  
lead	   to	   a	   partial	   inversion	   of	   the	   selectivity.	   A	  more	   efficient	  
control	   of	   the	   selectivity	   was	   more	   recently	   achieved	   with	  


























Anti-parallel (2 + 2)Parallel Hybrid (3 + 1)
Scheme 19. Usual G4DNA conformations
Scheme 20. H-Tel-mediated Diels-Alder cycloadditions
Cu(II), G4DNA
ligand free

















such	  as	  potassium	  or	  ammonium	  ions.87	   	  
	   Removing	   the	   ligand	   parameter	   out	   of	   the	   equation	  
therefore	   allows	   both	   excellent	   selectivities	   and	   reactivities	  
and	   enables	   a	   very	   interesting	   rational	   to	   the	   catalytic	  
effectiveness	   of	   the	   different	   conformations	   of	   G4DNA.	  
However,	   the	   ligand-­‐free	   approach	   unfortunately	   brings	  
certain	   uncertainty	   on	   the	   structure	   and	   position	   of	   the	  
catalyst	   in	   the	   scaffold.	   Hence,	   several	   studies	   turned	   their	  
attention	   on	   the	   use	   of	   G4DNA-­‐specific	   ligands	   in	   both	  
supramolecular	  and	  covalent	  approaches.	  
	   The	   founding	  work	  of	  Moses	  and	  co-­‐workers	  showed	  that	  	  
G-­‐quadruplexes,	   in	   conjunction	  with	  bypiridine	  based	   ligands,	  
could	   induce	   enantioselectivity	   in	   the	   copper-­‐catalysed	  Diels-­‐
Alder	   cycloaddition.	  Michael	   additions	  were	   also	   investigated	  
by	   Zhao	   et	   al.	   using	   a	   closely	   related	   approach	   based	   on	  
bipyridine	  ligands.88	  Experimental	  parameters	  such	  as	  buffers,	  
co-­‐solvents	   or	   sonication	   times	   proved	   to	   be	   of	   the	   highest	  
importance	  on	   the	   enantioselective	   outcome	  of	   the	   reaction.	  
Yet	   once	   again,	   modest	   selectivities	   were	   observed	   and	   no	  
structural	  comprehension	  seems	  easily	  reachable.	  
	   Wilking	   et	   al.	   envisioned	   to	   tackle	   this	   double	   issue	   by	  
using	  known	  G-­‐quadruplexes	  binders,	  cationic	  porphyrins	  L18,	  
as	   copper	   ligands.89	   Their	   interaction	   with	   G4DNA	   occurs	   by	  	  
π-­‐stacking	   onto	   one	   of	   the	   two	   accessible	   G-­‐quartet.	   Several	  
cationic	   porphyrins	   were	   engaged	   in	   catalysis	   and	   led	   to	  
encouraging	   enantioselectivities,	   as	   high	   as	   56%	  ee,	   obtained	  
with	   the	   Cu(L18)	   complex	   and	   h-­‐Tel	   (Scheme	   22).	  
CD	  experiments	  once	  again	  demonstrated	   the	  great	   influence	  
of	  sodium	  and	  potassium	  ions	  and	  confirmed	  the	  hybrid	  (3+1)	  
as	   the	   adopted	   conformation.	   However,	   the	   sequence	  
screening	   brought	   the	  most	   valuable	   information	   concerning	  
the	  binding	  site	  of	  the	  ligands.	  Base	  substitutions	  on	  the	  3’-­‐end	  
of	  the	  h-­‐Tel-­‐derived	  sequences	  indeed	  led	  to	  extremely	  varying	  
selectivities	  whereas	  substitutions	  on	  the	  5’-­‐end	  had	  a	  limited	  
impact.	   A	   binding	   on	   the	   3’-­‐end	   G-­‐quartet	   was	   therefore	  
logically	   suggested	   and	   enantiomeric	   excesses	   could	   be	  
increased	   up	   to	   (+)	   68%	   upon	   rationalized	   sequence	  
optimization.	  
	   	  A	   new	   class	   of	   G-­‐quartet	   stacking	   ligands	   was	   later	  
developed	  by	  Li	  and	  co-­‐workers	  for	  the	  same	  catalytic	  purpose	  
(Scheme	   22).90	   By	   taking	   advantage	   of	   the	   known	   affinity	   of	  




were	   able	   to	   increase	   the	   catalytic	   activity	   of	   G4DNA	   for	   the	  
Diels-­‐Alder	   cycloaddition.	   Moreover,	   spectroscopic	   analysis	  
(CD,	  UV	  and	   ITC)	  proved	  that	   the	   interaction	  with	   the	  chosen	  
terpyridine-­‐derived	   ligand	   L19	   was	   both	   stabilizing	   and	  
regulating	   the	   G-­‐quadruplex	   structure.	   The	   screening	   of	  
various	   ligands	   later	   confirmed	   this	   influence,	   as	   a	   charged	  
amino-­‐alkyl	  side	  chain	  was	  shown	  to	  have	  a	  better	  affinity	  for	  
the	   G-­‐quartet.	   As	   previously	   stated,	   the	   selectivity	   could	   be	  
further	   increased	  upon	   addition	   of	   stabilizing	   species	   such	   as	  
ammonium	  cations,	  preforming	  and	  stabilizing	   the	  scaffold.	  A	  
scope	   of	   the	   reaction	   was	   finally	   conducted	   after	   these	  
optimizations	  and	  excellent	  enantioselectivities	  were	  observed	  
on	   various	   substrates,	   with	   ees	   ranging	   from	   (+)	   93%	   to	  
(+)	  99%.	  
	   More	   recently,	   two	  major	   studies	   reintroduced	   the	  use	  of	  
bipyridine-­‐based	   ligands	   in	   order	   to	   widen	   the	   field	   of	  
possibilities	   for	   G4DNA-­‐mediated	   catalysis.	   Li	   and	   co-­‐workers	  
used	   dmbpy	   L12	   in	   a	   supramolecular	   fashion	   in	   order	   to	  
develop	   an	   enantioselective	   sulfoxidation	   reaction	  
(Scheme	  23).91	  While	  	  several	  attempts	  were	  made	  to	  develop	  
an	   asymmetric	   oxidation	   reaction	   with	   porphyrin-­‐based	  
ligands,	   no	   selectivity	  was	   observed.	   Interestingly,	   the	   use	   of	  
L12	   in	  conjunction	  with	  a	  natural	  21mer	  h-­‐Tel	  sequence	   in	   its	  
antiparallel	   stabilized	   conformation	   lead	   to	   77%	   ee	  
(Scheme	  23).	  Yet,	  a	  pronounced	  substrate-­‐specificity	  seems	  to	  
occur	  (ees	  ranging	  from	  6%	  to	  77%)	  and	  the	  observation	  of	  the	  
very	  weak	  binding	  existing	  between	  the	  scaffold	  and	  the	  ligand	  
surely	   keeps	   from	   having	   a	   clear	   view	   of	   the	   nature	   of	   the	  
interaction.	  
	   To	   overcome	   this	   limitation,	   Jäschke	   and	   co-­‐workers	  
recently	   envisioned	   the	   covalent	   attachment	   of	   this	   specific	  
ligand	   to	   the	   G4DNA	   scaffold.92	   As	  we	   previously	   stated,	   the	  
covalent	   attachment	   is	   surely	   the	   best	   way	   to	   ensure	   the	  
position	  of	  metallic	  co-­‐factor	  and	  numerous	  studies	  confirmed	  
its	   efficacy,	   especially	   with	   dmbpy	   L12.	   A	   specific	   type	   of	  
sequence,	  c-­‐kit	  wild	  type,	  was	  selected	  for	  its	  ability	  to	  adopt	  a	  
parallel	   conformation.	   The	   introduction	   of	   the	   ligand	   was	  
conducted	   by	   a	   Sonogishira	   coupling	   between	   bipyridine-­‐
derived	   alkynes	   and	   DMT-­‐protected	   IdU.	   The	   corresponding	  
amidites	  were	  then	  engaged	  in	  the	  automated	  synthesis	  of	  the	  
c-­‐kit	  derived	  sequences.	  	  
	  
	  
Scheme 21. Enantioselective Diels-Alder cycloaddition catalysed by higher-order 
h-Tel G4DNA.
h-Tel [up to ee = (+) 74%]
























Hybrid (3 + 1)Parallel
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h-Tel [up to ee = (−) 58%]
higher order h-Tel  [up to ee = (+) 92%]
higher order h-Tel  [up to ee = (−) 90%]
Scheme 22. Supramolecular approach, application to Diels-Alder cycloadditions
Cu(II), G4DNA
L18-L19



















with L18 (KCl 50 mM)  [up to (+) 68% ee]












	   By	   using	   a	   model	   copper-­‐catalysed	   Michael	   addition	   on	  
α,β-­‐unsaturated	   acyl	   imidazoles	   such	   as	   4	   (Scheme	   24),	   the	  
authors	   were	   able	   to	   observe	   both	   good	   reactivities	   and	  
unprecedented	   selectivities,	   with	   ees	   up	   to	   (−)	   92%	   using	   an	  
hexynyl-­‐derived	   bipyridine	   introduced	   in	   position	   10	   of	   the	  
c-­‐kit.	   Moreover,	   they	   observed	   that	   the	   introduction	   of	   this	  
modification	   on	   position	   12	   could	   lead	   to	   a	   very	   interesting	  
reversal	  of	  selectivity	  to	  (+)	  52%	  ee	  without	  any	  changes	  in	  the	  
architecture	  of	  the	  scaffold.	  A	  complete	  scope	  of	  the	  reaction	  
was	  conducted	  and	  the	  trend	  persisted,	  illustrating	  once	  again	  





4.2	  Mirror-­‐image	  DNA	  
A	   number	   of	   teams	   have	   been	   interested	   in	   controlling	   the	  
enantioselectivity	  outcome	  of	  the	  various	  reactions	  developed	  
so	   far.	   By	   varying	   the	   type	   of	  metallic	   co-­‐factor,	   changing	   its	  
position	   on	   the	   scaffold	   or	   tuning	   the	   conformation	   of	   the	  
secondary	   structure,	   an	   inversion	   of	   the	   overall	   selectivity	  
could	   be	   observed.79,86,87,89,92	   Nevertheless,	   these	   selectivity	  
inversions	  remained	  reaction	  or	  substrate-­‐specific	  and	  most	  of	  
the	  time	  partial.	  To	  address	  this	  shortage,	  our	  group	  opted	  for	  
the	   use	   of	   mirror-­‐image	   oligonucleotides;	   by	   far	   the	   most	  
reliable	  method	  to	  selectively	  access	  either	  enantiomer	  of	  any	  
given	   reaction.93	   The	   mirror-­‐image	   form	   of	   DNA,	   L-­‐DNA	   is	  
purely	  synthetic	  but	  possesses	  the	  same	  physical	  properties	  as	  
common	   D-­‐DNA.94	   The	   D	   and	   L	   equivalents	   of	   two	   different	  
auto-­‐complimentary	   sequences	   were	   thus	   prepared	   and	  




	   Interestingly,	   we	   were	   able	   to	   selectively	   access	   either	  
enantiomer	  by	  simply	  switching	  the	  orientation	  of	  the	  helix.	  
	  
4.3	  Solid-­‐supported	  DNA	  
In	   order	   to	   increase	   the	   applicability	   of	   catalytic	   strategies,	  
various	   paths	   can	   be	   explored.	   As	   far	   as	   DNA-­‐mediated	  
catalysis	   is	   concerned,	   the	   scalability	   of	   the	   reactions	   and	  
reusability	   of	   the	   bio-­‐inorganic	   complexes	   remained	   quite	  
challenging	   until	   recently	   and	   the	   development	   of	   supported	  
DNA-­‐based	   catalysts.	   Recently,	   the	   concept	   has	   been	  
successfully	   put	   into	   operation	   by	   making	   use	   of	   silica	   and	  
cellulose	   as	   solid	   supports	   for	   oligonucleotides	   and	   tested	   in	  
the	  Diels-­‐Alder,	  Friedel-­‐Crafts	  and	  Michael	  additions.95,96	  
	   The	  first	  supported	  catalyst	  was	  reported	  by	  Sugiyama	  and	  
co-­‐workers	   and	   involved	   the	   immobilization	   of	   st-­‐DNA	   onto	  
ammonium-­‐functionalised	   silica	   beads	   (Scheme	   26).95	   Using	  
the	  reported	  supramolecular	  strategy,	  the	  Diels-­‐Alder	  reaction	  
afforded	   an	   extremely	   satisfying	   94%	   ee,	   comparable	   to	   the	  
99%	   ee	   achieved	   by	   the	   homogeneous	   Diels-­‐Alder	   reaction.	  
Recyclability	   was	   achieved	   using	   a	   rather	   simple	   washing	  
protocol	  of	  the	  supported	  catalyst,	  followed	  by	  the	  re-­‐addition	  
of	  the	  metallic	  co-­‐factor.	  Up	  to	  ten	  cycles	  could	  be	  successfully	  
achieved	  using	   the	   same	  supported	  oligonucleotide	  with	  only	  





	   Our	   group	   was	   also	   involved	   in	   the	   development	   of	   a	  
supported	  catalyst.	   Instead	  of	  ammonium-­‐functionalised	  silica	  
beads,	   we	   opted	   for	   cellulose	   supported-­‐ct-­‐DNA	  
(Scheme	  27).96	  The	  latter	  was	  tested	  in	  conjunctin	  with	  L12	   in	  
the	  asymmetric	  Friedel-­‐Crafts	  alkylation	  and	  in	  various	  Michael	  
additions.	   Once	   again,	   high	   yields	   and	   high	   selectivities	  were	  
obtained,	   while	   no	   loss	   in	   selectivity	   was	   observed	   after	  
10	  runs.	  
Scheme 23. G4DNA-mediated sulfoxidation reaction
Cu(II), G4DNA
L12










44a R1 = o-ClPh, R2 = Me [ee = (+) 77%]
44b R1 = m-ClPh, R2 = Me [ee = (+) 25%]
44c R1 = m-Tol, R2 = Me  [ee = (+) 34%]
44d R1 = p-Tol, R2 = Me  [ee = (+) 29%]
44e R1 = o-MeOPh, R2 = Me  [ee = (+) 18%]
44f R1 = 1-Napthyl, R2 = Me [ee = (+) 6%]
44g R1 = Ph, R2 = Et [ee = (+) 23%]
44h R1 = Ph, R2 = Ph [ee = (+) 32%]
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   We	  were	   also	   able	   to	   implement	   the	  method	   to	   a	   single-­‐
pass,	   continuous-­‐flow	   process	   and	   for	   the	   first	   time	   perform	  
reactions	  on	  a	  synthetically	  useful	  scale.	  The	  cellulose-­‐ct-­‐DNA-­‐
Cu(dmbpy)	  was	  simply	  loaded	  into	  a	  chromatography	  column,	  
with	  the	  reagents	  being	  fed	  into	  the	  reaction	  via	  a	  syringe	  in	  a	  
30:1	   MOPS	   buffer/MeOH	   solution.	   Using	   the	   Friedel-­‐Crafts	  
alkylation	  of	  5-­‐methoxyindole	  as	  model	   reaction,	   the	  concept	  
afforded	  high	  selectivities	  (up	  to	  80%	  ee)	  and	  an	  appealing	  and	  
successful	  mmol	   scale	   protocol	   which	   is	   roughly	   a	   thousand	  





Conclusion	  &	  Perspectives	  
	  
During	  the	  past	  decade,	  the	  use	  of	  oligonucleotides	  as	  a	  chiral	  
framework	  for	  asymmetric	  transformations	  has	  met	  a	  growing	  
success.	   From	   the	   pioneering	  work	   of	   Roefles	   and	   Feringa	   to	  
the	   latest	  advances	   in	   tuning	   the	  conformation	  of	  G4DNA	   for	  
the	   control	   of	   the	   selectivity,	   the	   spectrum	   of	   achievable	  
transformations	   using	   oligonucleotides	   as	   chiral	   scaffolds	   has	  
been	  tremendously	  broadened.	  
	   The	   comprehension	   of	   the	   binding	  modes	   of	   the	  metallic	  
co-­‐factor	   has	   also	   drawn	   the	   attention	   of	   many	   groups.	  
Indeed,	   it	   rapidly	   became	   obvious	   that	   attaining	   the	   highest	  
selectivities	  could	  only	  be	  achieved	  by	  a	  clear	  comprehension	  
of	   the	   transfer	   of	   chirality	   from	   the	   oligonucleotide	   to	   the	  
substrates,	   through	   the	   ligand,	   the	   key	   element	   of	   the	   chiral	  
micro-­‐environment.	   Many	   ligand-­‐oriented	   strategies	   have	  
therefore	   been	   envisaged.	   The	   supramolecular	   approach	  
enabled	   the	   field	   to	   acquire	   its	   first	   distinctions,	   but	   was	  
rapidly	   joined	   by	   the	   covalent	   strategy,	   which	   allowed,	   by	  
tailoring	  the	  oligonucleotide	  scaffold,	  to	  gain	  precious	  insights	  
on	   the	   positioning	   of	   the	   ligand	   and	   the	   influence	   of	   the	  
surrounding	   environment.	   As	   for	   non-­‐canonical	   structures,	  
such	   as	   G-­‐quadruplexes	   or	   supported-­‐DNA,	   their	   use	   was	  
proved	   to	   be	   extremely	   beneficial	   and	   appealing	   to	   achieve	  
reactions	  at	  high	  levels	  of	  enantioselectivity	  or	  at	  synthetically	  
relevant	   scales	   but	   also	   revealed	   new	   scaffold-­‐ligands	  
assemblies,	  showing	  unprecedented	  and	  useful	  features.	  
	   At	  this	  point,	  we	  have	  never	  been	  so	  close	  to	  unravelling	  a	  
path	  to	  the	  perfect	  catalyst,	  simple	  and	  efficient,	  modular	  and	  
universal.	   In	   a	   very	   recent	   study,	   Roelfes	   and	   co-­‐workers	  
reported	   a	   DNA-­‐mediated	   carben	   transfer	   reaction,97	  making	  
use	   of	   cationic	   iron	   porphyrin-­‐derived	   complexes	   as	   metallic	  
co-­‐factors.	   Although	   interesting	   enantioselectivities	   were	  
achieved,	   the	   authors	   highlighted	   another	  major	   facet	   of	   the	  
concept.	  Indeed,	  the	  different	  porphyrin-­‐based	  ligands	  showed	  
wide-­‐ranging	  behaviours	  in	  terms	  of	  catalytic	  efficacies,	  rightly	  
attributed	  to	  the	  unique	  binding-­‐modes	  showcased	  by	  each	  of	  
these	  compounds.	  The	  key	  parameters	  are	  again	  eye-­‐catching:	  
the	   nature	   of	   the	   binding	   mode,	   the	   affinity	   for	   the	  
oligonucleotide,	  and	  the	  proximity	  of	  the	  helix.	  
	   Among	   the	   large	   panel	   of	   metalloenzymes,	  
oligonucleotides	   seem	   to	   stand	   out,	   but	   in	   order	   to	   ensure	  
their	   success,	   the	   efforts	   now	   have	   to	   be	   carefully	  
orchestrated.	   Nonethless,	   if	   the	   discovery	   of	   new	   reactions,	  
systems,	   or	   useable	   topologies	   comes	   along	   with	   rational	  
structure/selectivity	   correlation	   studies	   and	   a	   deeper	  
understanding	   of	   the	   interactions	   existing	   between	   the	  
scaffold	  and	  the	  ligands,	  the	  future	  of	  DNA-­‐based	  asymmetric	  
catalysis	  will	  be	  bright	   in	   the	   field	  of	  bio-­‐hybrid	  catalysis.	   In	  a	  
very	  recent	  study,	  Wagenknecht	  and	  co-­‐workers	  enforced	  the	  
applicability	  of	  DNA-­‐based	  asymmetric	  catalysis	  by	  reporting	  a	  
photocatalysed	   [2+2]	   cycloaddition	   using	   benzophenone-­‐
substituted	   DNA	   sequences.98	   Although	   the	   selectivity	  
obtained	   with	   these	   chiral	   photoDNAzymes	   still	   remains	  
moderate,	   this	   unprecedented	   methodology	   opens	   new	  
perspectives	  in	  the	  field	  of	  DNA-­‐based	  asymmetric	  catalysis.	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